MARKET

ANIX

ANIX

Anixa Biosciences Inc
NASDAQ

Real-time Quotes | Nasdaq Last Sale

1.610
-0.010
-0.62%
Opening 10:27 03/31 EDT
OPEN
1.630
PREV CLOSE
1.620
HIGH
1.670
LOW
1.580
VOLUME
18.07K
TURNOVER
--
52 WEEK HIGH
5.45
52 WEEK LOW
1.330
MARKET CAP
33.82M
P/E (TTM)
-3.4698
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of ANIX and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 1 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average ANIX stock price target is 8.00 with a high estimate of 8.00 and a low estimate of 8.00.

EPS

ANIX News

More
  • Here's Why We're Watching Anixa Biosciences's (NASDAQ:ANIX) Cash Burn Situation
  • Simply Wall St. · 03/23 11:28
  • The Daily Biotech Pulse: AstraZeneca Faces Setback In Ovarian Cancer Study, Mallinckrodt To Explore COVID-19 Treatment, Imara IPO
  • Benzinga · 03/12 11:37
  • The Daily Biotech Pulse: NY State Endorses Mallinckrodt's Opioid Settlement, Kamada To Work On COVID-19 Treatment
  • Benzinga · 03/11 12:05
  • The Daily Biotech Pulse: Mesoblast To Test Candidate On Coronavirus Symptoms, Proxy Battle Ahead For Rockwell Medical, Glaukos to Join S&P SmallCap 600 Index
  • Benzinga · 03/10 13:19

Industry

Biotechnology & Medical Research
-0.35%
Pharmaceuticals & Medical Research
-0.27%

Hot Stocks

Symbol
Price
%Change

About ANIX

Anixa Biosciences, Inc. is a biotechnology company. The Company is developing a cancer immunotherapy program, which leverages chimeric endocrine receptor t-cell (CER-T) technology, and is engaged in developing a diagnostic platform called Cchek, for the early detection of tumor-based cancers. The Cchek liquid biopsy technology is a series of non-invasive blood tests for early detection of solid tumors based on the body's immune response to a malignancy by detecting the presence, absence and quantity of certain immune cells that exist in and around a tumor and that enter the blood stream. This technology enables cancer detection in its earliest stages in efforts to treat patients when the disease is curable. The Company has developed techniques and protocols for measuring the subtle immunological changes that occur in the blood stream during tumor development. Through its protocols, the Company has detected the biomarkers in the peripheral blood of biopsy verified cancer patients.
More

Webull offers kinds of Anixa Biosciences Inc stock information, including NASDAQ:ANIX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ANIX stock news, and many more online research tools to help you make informed decisions.